Loading...
Loading...
Smart Money Score
Composite context from Form 4, 13F and congressional disclosures; not a forecast.
Of the 19 tracked institutions holding VRTX, 12 have a 3-year clone track record — 9 of them beat the S&P. Average holder's clone alpha: +3.2pt. It's a gauge of who owns the name, not just how many.
Among the 19 tracked institutional investors we monitor, VRTX (VERTEX PHARMACEUTICALS INC) is held with a combined value of $43.05B across 88,787,507 shares. The largest holder is BlackRock, Inc. with a position worth $11.98B (0.18% of their portfolio). Point72 Asset Management, L.P. opened a new position in the most recent quarter. 9 funds increased their holdings. 9 funds reduced their position.
Total Institutional Value
$43.05B
Total Shares Held
88,787,507
Institutional Holders
19
% of Shares Outstanding
35.0%
of 253.46M shares · SEC 2026-07-31
Days to Cover
3.1+5.2%
4.15M shares short · FINRA 2026-08-14
Tracked 13F institutions hold 35.0% of VRTX's shares outstanding. This is a floor: 13F filings arrive on a ~45-day lag and we track only a subset of institutional filers, so true institutional ownership is higher. Shares-outstanding is the latest SEC cover-page figure (as of 2026-07-31), not a live float.
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
0
$0
69
$80.97M
Total Transactions
69
Last 12 months
| Date | Insider | Code | Type | Shares | Value |
|---|---|---|---|---|---|
| Jul 2, 2026 | Duncan McKechnie | S | Sale | 1,541 | $799.78K |
| Jul 2, 2026 | Ourania Tatsis | S | Sale | 1,500 | $787.49K |
| Jul 1, 2026 | Joy Liu | S | Sale | 828 | $416.24K |
| Jun 26, 2026 | Carmen Bozic | S | Sale | 596 | $287.57K |
| Jun 18, 2026 | Carmen Bozic | S | Sale | 1,020 | $471.41K |
| Jun 15, 2026 | Carmen Bozic | S | Sale | 4,062 | $1.83M |
| Jun 5, 2026 | Carmen Bozic | S | Sale | 1,745 | $785.25K |
| Jun 1, 2026 | Joy Liu | S | Sale | 828 | $364.25K |
| May 29, 2026 | Carmen Bozic | S | Sale | 1,974 | $888.30K |
| May 15, 2026 | Mark E. Bunnage | S | Sale | 33 | $14.96K |
Showing 10 of 69 transactions
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $11.98B | 0.18% | +0.6% |
| 2 | VANGUARD GROUP INC | $10.93B | 0.16% | -0.5% |
| 3 | Capital Research Global Investors | $9.68B | 1.35% | -7.7% |
| 4 | STATE STREET CORP | $5.90B | 0.17% | +1.2% |
| 5 | WELLINGTON MANAGEMENT GROUP LLP | $1.61B | 0.28% | +1.1% |
| 6 | PRICE T ROWE ASSOCIATES INC /MD/ | $858.56M | 0.09% | -1.8% |
| 7 | FMR LLC | $723.81M | 0.03% | -27.9% |
| 8 | AQR CAPITAL MANAGEMENT LLC | $305.00M | 0.11% | +260.3% |
| 9 | CITADEL ADVISORS LLC | $253.55M | 0.15% | +50.4% |
| 10 | MILLENNIUM MANAGEMENT LLC | $232.67M | 0.16% | +156.9% |
| Member | Type | Date |
|---|---|---|
| David J. Taylor | Sell | Aug 26, 2026 |
| Alan Armstrong | Buy | Mar 27, 2026 |
| David J. Taylor | Sell | Jan 29, 2026 |
| David J. Taylor | Buy |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of VRTX with a position worth $11.98B, representing 0.18% of their portfolio. In total, 19 institutional investors hold VRTX with a combined value of $43.05B.
In the most recent quarter, 1 fund opened a new position in VRTX. Additionally, 9 increased their holdings and 9 reduced their positions.
Institutional investors hold $43.05B worth of VRTX stock across 19 positions. The largest institutional holder is BlackRock, Inc. with $11.98B in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For VRTX, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their VRTX positions.
Alpha = the manager's 3-year clone return minus the S&P 500. A skilled roster is a stronger tell than a crowded one — though even skilled managers' edge doesn't reliably survive the 13F disclosure lag. Why →
| Aug 7, 2025 |
| Lisa McClain | Sell | Jun 11, 2025 |
| Lisa McClain | Sell | Jun 10, 2025 |
| Jefferson Shreve | Sell | May 12, 2025 |
| Byron Donalds | Sell | Mar 20, 2025 |
Showing 8 of 15. STOCK Act disclosures lag up to 45 days.
Last Close
$521.12
2026-09-09
YTD
+15.3%
80% of 52-week range
